A large-scale clinical trial conducted by the World Health Organization has determined that Gilead Sciences Inc.’s remdesivir had little or no effect on COVID-19 patients’ chances of survival or length of hospital stay. The antiviral drug had been granted Emergency Use Authorization (EUA) by the Food and Drug Administration inread more

On September 22, 2020, the United States marked a grim milestone in the ongoing COVID-19 pandemic, with the coronavirus having killed its 200,000th victim. The number of American casualties currently stands at 203,800, the highest of any single nation in the world, with the U.S. suffering over one-fifth of theread more

Earlier this year, a Canadian tourist became the first known civilian to exhibit symptoms consistent with a mysterious affliction previously only seen in U.S. and Canadian diplomats, dubbed “Havana syndrome” by researchers that leaves its victims with a range of neurological impairments and effects. Although speculation as to the cause behindread more